MedTrace Logo

2% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) Fistula

NCT00993746 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2010-05-17

No results posted yet for this study

Summary

Will the technique of adding lidocaine to bupivacaine fasten the onset of bupivacaine alone for infraclavicular brachial plexus block in end-stage renal disease (ESRD) patient?

Conditions

  • Infraclavicular Brachial Plexus Block

Interventions

DRUG

Bupivacaine plus lidocaine

Bupivacaine 20 ml plus lidocaine 10 ml

DRUG

Bupivacaine 30 ml

Bupivacaine 30 ml for ultrasound guided infraclavicular brachial plexus block

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Orawan Pongrawewan, MD · Siriraj Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-09-30
Completion
2011-09-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00993746 on ClinicalTrials.gov